Literature DB >> 33459643

Modifiable, Non-Modifiable, and Clinical Factors Associated with Progression of Alzheimer's Disease.

David A Loeffler1.   

Abstract

There is an extensive literature relating to factors associated with the development of Alzheimer's disease (AD), but less is known about factors which may contribute to its progression. This review examined the literature with regard to 15 factors which were suggested by PubMed search to be positively associated with the cognitive and/or neuropathological progression of AD. The factors were grouped as potentially modifiable (vascular risk factors, comorbidities, malnutrition, educational level, inflammation, and oxidative stress), non-modifiable (age at clinical onset, family history of dementia, gender, Apolipoprotein E ɛ4, genetic variants, and altered gene regulation), and clinical (baseline cognitive level, neuropsychiatric symptoms, and extrapyramidal signs). Although conflicting results were found for the majority of factors, a positive association was found in nearly all studies which investigated the relationship of six factors to AD progression: malnutrition, genetic variants, altered gene regulation, baseline cognitive level, neuropsychiatric symptoms, and extrapyramidal signs. Whether these or other factors which have been suggested to be associated with AD progression actually influence the rate of decline of AD patients is unclear. Therapeutic approaches which include addressing of modifiable factors associated with AD progression should be considered.

Entities:  

Keywords:  Alzheimer’s disease; baseline cognition; extrapyramidal signs; genetic factors; malnutrition; neuropsychiatric symptoms; progression

Year:  2021        PMID: 33459643     DOI: 10.3233/JAD-201182

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  5 in total

Review 1.  Vascular Cognitive Impairment (VCI).

Authors:  Tatjana Rundek; Magdalena Tolea; Taylor Ariko; Eric A Fagerli; Christian J Camargo
Journal:  Neurotherapeutics       Date:  2021-12-22       Impact factor: 6.088

2.  Association between Apoϵ4 allele and cardiometabolic and social risk factors with cognitive impairment in elderly population from Bogota.

Authors:  Olga Lucia Pedraza; Isis Camacho; Fabio Alexander Sierra; Rubio-Gómez Cladelis; Ana Maria Salazar; Maria Camila Montalvo; Hector Daniel Morillo; Angela Lozano; Luz Dary Gutiérrez-Castañeda; Lilian Torres-Tobar; Cesar Piñeros
Journal:  Dement Neuropsychol       Date:  2021 Oct-Dec

3.  Dapsone is an anticatalysis for Alzheimer's disease exacerbation.

Authors:  Jong Hoon Lee; Badar Kanwar; Chul Joong Lee; Consolato Sergi; Michael D Coleman
Journal:  iScience       Date:  2022-04-20

Review 4.  Alzheimer's Disease and Stroke: A Tangled Neurological Conundrum.

Authors:  Anuradha Gupta; Kamsika Uthayaseelan; Kivonika Uthayaseelan; Monika Kadari; Muhammad Subhan; Nisha Saji Parel; Parimi Vamsi Krishna; Ibrahim Sange
Journal:  Cureus       Date:  2022-05-15

5.  Sex-specific accelerated decay in time/activity-dependent plasticity and associative memory in an animal model of Alzheimer's disease.

Authors:  Sheeja Navakkode; Jessica Ruth Gaunt; Maria Vazquez Pavon; Vibhavari Aysha Bansal; Riya Prasad Abraham; Yee Song Chong; Toh Hean Ch'ng; Sreedharan Sajikumar
Journal:  Aging Cell       Date:  2021-11-18       Impact factor: 9.304

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.